Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Shigeo Fuji, MD, Sung-Won Kim, MD, Takahiro Fukuda, MD, Shin-ichiro Mori, MD, Satoshi Yamasaki, MD, Yuriko Morita-Hoshi, MD, Fusako Ohara-Waki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 1968.

https://doi.org/10.1182/blood.V110.11.1968.1968

Published: 2007

Journal Articles

Efficient Expansion of Lymphocytes in a Culture System with Solid Phase Anti-CD3 and Anti-CD28 Monoclonal Antibodies.

Atsuko Soeda, Atsushi Kondo, Hiroaki Makiyama, Yuriko Morita, Noriko Takahashi, Hideo Yagita, Yoichi Takaue, Yuji Heike

Blood (2006) 108 (11): 3648.

https://doi.org/10.1182/blood.V108.11.3648.3648

Published: 2006

Journal Articles

Serum Amyloid A (SAA) as a Molecular Marker for Pre-Engraftment Immune Reactions (PIR) after Cord Blood Transplantation.

Yuriko Morita-Hoshi, Yuji Heike, Yuka Ohsaki, Mieko Shiwa, Kazuhiro Masuoka, Atsushi Wake, Shuichi Taniguchi, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 3127.

https://doi.org/10.1182/blood.V108.11.3127.3127

Published: 2006

Journal Articles

Imaging the Differential Engraftment of GFP-Expressing Spleen and Bone Marrow Cells in Various Organs after Reduced-Intensity Stem Cell Transplantation in Mice Model.

Yuji Heike, MD, PhD, Zhijian Yang, PhD, Huaiyu Ma, PhD, Robert Hoffmann, PhD, Yuriko Morita, MD, Atsuko Soeda, MD, Hiroaki Makiyama, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2006) 108 (11): 3228.

https://doi.org/10.1182/blood.V108.11.3228.3228

Published: 2006

Journal Articles

Evaluation of Pre-Transplantation T-Cell Receptor Excision Circles (TREC) in Reduced-Intensity Stem Cell Transplantation (RIST) Recipients.

Yuriko Morita-Hoshi, Yuji Heike, Shizuka Yamagata, Kinuko Tajima, Shuichi Taniguchi, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 2905.

https://doi.org/10.1182/blood.V108.11.2905.2905

Published: 2006

Journal Articles

Fever Following Bortezomib Administration Correlated with Serum Cytokine Levels in Patients with Multiple Myeloma (MM).

Dai Maruyama, MD, Takashi Watanabe, MD, Fusako Ohara, MD, Kazuki Tanimoto, MD, Sung-Won Kim, MD, Satoshi Yamasaki, MD, Yuriko Morita, MD, Yukio Kobayashi, MD, Kensei Tobinai, MD

Blood (2006) 108 (11): 5092.

https://doi.org/10.1182/blood.V108.11.5092.5092

Published: 2006

Journal Articles

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Eiji Usui, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2015.

https://doi.org/10.1182/blood.V106.11.2015.2015

Published: 2005

Journal Articles

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Ruri Kato, MD, Takahiro Fukuda, MD, Eiji Usui, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2731.

https://doi.org/10.1182/blood.V106.11.2731.2731

Published: 2005

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Dai Maruyama, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Eiji Usui, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 1142.

https://doi.org/10.1182/blood.V106.11.1142.1142

Published: 2005

Journal Articles

Evaluation of Cytomegalovirus (CMV)-Specific Cytotoxic T Lymphocyte (CTL) Monitoring Procedures with Tetramer and Intracellular IFN-γ Assay after Allogeneic Hematopoietic Stem Cell Transplantation (SCT).

Yuriko Morita, Mami Hosokawa, Yuji Heike, Tohru Sasaki, Michiko Ebisawa, Shin-ichiro Mori, Ryuji Tanosaki, Masahiro Kami, Mutsuko Ohnishi, Osamu Miura, Kensei Tobinai, Yoichi Takaue

Blood (2004) 104 (11): 3161.

https://doi.org/10.1182/blood.V104.11.3161.3161

Published: 2004

Journal Articles

Follow-Up of WT1-Specific Cytotoxic T Lymphocytes (CTL) with Tetramer-Based Analysis after Allogeneic Stem Cell Transplantation (SCT) in Patients with Renal Cell Carcinoma (RCC).

Yuriko Morita, Mami Hosokawa, Yuji Heike, Tohru Sasaki, Michiko Ebisawa, Shin-ichiro Mori, Ryuji Tanosaki, Masahiro Kami, Kisato Nosaka, Mutsuko Ohnishi, Osamu Miura, Kensei Tobinai, Yoichi Takaue

Blood (2004) 104 (11): 2122.

https://doi.org/10.1182/blood.V104.11.2122.2122

Published: 2004

NARROW

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Efficient Expansion of Lymphocytes in a Culture System with Solid Phase Anti-CD3 and Anti-CD28 Monoclonal Antibodies.

Serum Amyloid A (SAA) as a Molecular Marker for Pre-Engraftment Immune Reactions (PIR) after Cord Blood Transplantation.

Imaging the Differential Engraftment of GFP-Expressing Spleen and Bone Marrow Cells in Various Organs after Reduced-Intensity Stem Cell Transplantation in Mice Model.

Evaluation of Pre-Transplantation T-Cell Receptor Excision Circles (TREC) in Reduced-Intensity Stem Cell Transplantation (RIST) Recipients.

Fever Following Bortezomib Administration Correlated with Serum Cytokine Levels in Patients with Multiple Myeloma (MM).

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Evaluation of Cytomegalovirus (CMV)-Specific Cytotoxic T Lymphocyte (CTL) Monitoring Procedures with Tetramer and Intracellular IFN-γ Assay after Allogeneic Hematopoietic Stem Cell Transplantation (SCT).

Follow-Up of WT1-Specific Cytotoxic T Lymphocytes (CTL) with Tetramer-Based Analysis after Allogeneic Stem Cell Transplantation (SCT) in Patients with Renal Cell Carcinoma (RCC).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only